ZVRA
Zevra Therapeutics, Inc.Company with tickers: ZVRA
CIK
1434647
CUSIP
488445206
Shares Outstanding
59,115,084
13F Activity (30d)
124 filings
120 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $52,146,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $37,890,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.62 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.60 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |